Tissue-engineered skeletal muscle organoids for reversible gene therapy

Human Gene Therapy

Volumn 7, Issue 17, 1996, Pages 2195-2200

  Vandenburgh, Herman ^a,b,c   Del Tatto, Michael ^a   Shansky, Janet ^a   Lemaire, Julie ^a   Chang, Albert ^a   Payumo, Francis ^a   Lee, Peter ^a   Goodyear, Amy ^a   Raven, Latasha ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOPLASM; GENE THERAPY; GENETIC ENGINEERING; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; MOLECULAR GENETICS; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; SKELETAL MUSCLE;

ANIMALIA; MURINAE;

EID: 0029798172     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.17-2195     Document Type: Article

References (30)

1. ACSADI, G., DICKSON, G., LOVE, D.R., JANI, A., WALSH, F.S., GURUSINGHE, A., WOLFF, J.A., and DAVIES, K.E. (1991). Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352, 815-818.
2. AL-HENDY, A., HORTELANO, G., TANNENBAUM, G.S., and CHANG P.L. (1995). Correction of the growth defect in dwarf mice with nonautologous myoblasts - an alternate approach to somatic gene therapy. Hum. Gene Ther. 6, 165-175.
3. BARR, E., and LEIDEN, J.M. (1991). Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254, 1507-1509.
4. BEHARA, A.M., WESTCOTT, A.J., and CHANG, P.L. (1992). Intrathymic implants of genetically modified fibroblasts. FASEB J. 6, 2853-2858.
5. BELL, E., IVARSSON. B., and MERRILL, C. (1979). Production of tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. USA 76, 1274-1278.
6. BLAU, H.M., and SPRINGER, M.L. (1995a). Muscle-mediated gene therapy. N. Engl. J. Med. 333, 1554-1556.
7. BLAU, H.M., and SPRINGER, M.L. (1995b). Gene therapy - A novel form of drug delivery. N. Engl. J. Med. 333, 1204-1207.
8. CHEN, B.-F., CHANG, W.-C., CHEN, S.-T., CHEN, D.-S., and HWANG, L.-H. (1995). Long-term expression of the biologically active growth hormone in genetically modified fibroblasts after implantation into a hypophysectomized rat. Hum. Gene Ther. 6, 917-926.
9. CRYSTAL, R.G. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
10. DHAWAN, J., PAN, L.C., PAVLATH, G.K., TRAVIS, M.A., LANCTOT, A.M., and BLAU, H.M. (1991). Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509-1512.
11. FANG, J., ZHU, Y.-Y., SMILEY, E., BONADIO, J., ROULEAU, J.P., GOLDSTEIN, S.A., MCCAULEY, L.K., DAVIDSON, B.L., and ROESSLER, B.J. (1996). Stimulation of new bone formation by direct transfer of osteogenic plasmid DNA. Proc. Natl. Acad. Sci. USA 93, 5753-5758.
12. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1994). Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA. Hum. Gene Ther. 5, 1349-1356.
13. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1995). Myoblast transfer of human erythropoietin gene in a mouse of renal failure. J. Clin. Invest. 95, 1808-1813.
14. HEARTLEIN, M.W., ROMAN, V.A., JIANG, J.-L., SELLERS, J.W., ZULIANI, A.M., TRECO, D.A., and SELDEN, R.F. (1994). Long-term production and delivery of human growth hormone in vivo. Proc. Natl. Acad. Sci. USA 91, 10967-10971.
15. HUARD, J., ACSADI, G., JANI, A., MASSIE, B., and KARPATI, G. (1995). Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5, 949-958.
16. JIAO, S., WILLIAMS, P., BERG, R.K., HODGEMAN, B.A., LIU, L., REPETTO, G., and WOLFF, J.A. (1992). Direct gene transfer into nonhuman primate myofibers in vivo. Hum. Gene Ther. 3, 21-33.
17. JIAO, S., WILLIAMS, P., SAFDA, N., SCHULTZ, E., and WOLFF, J.A. (1993). Co-transplantation of plasmid-transfected myoblasts and myotubes into rat brains enables high levels of gene expression long-term. Cell Transpl. 2, 185-192.
18. LANGER, R., and VACANTI, J.P. (1993). Tissue engineering. Science 260, 920-926.
19. MA, J., YANG, Z., CHAO, J., and CHAO, L. (1995). Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. J. Biol. Chem. 270, 451-455.
20. NEUMEYER, A.M., DIGREGORIO, D.M., and BROWN, R.H., JR. (1992). Arterial delivery of myoblasts to skeletal muscle. Neurology 42, 2258-2262.
21. STROBL, J.S., and THOMAS, M.J. (1994). Human growth hormone. Pharmacol. Rev. 46, 1-34.
22. VANDENBURGH, H.H., KARLISCH, P., and FARR, L. (1988). Maintenance of highly contractile skeletal myotubes in collagen gels. In Vitro 24, 166-174.
23. VANDENBURGH, H.H., SWASDISON, S., and KARLISCH, P. (1991). Computer aided mechanogenesis of skeletal muscle organs from single cells in vitro. FASEB J. 5, 2860-2867.
24. VANDENBURGH, H.H., SOLERSSI, R., SHANSKY, J., ADAMS, J.W., HENDERSON, S.A., and LEMAIRE, J. (1995). Response of neonatal rat cardiomyocytes to repetitive mechanical stimulation in vitro. Ann. N.Y. Acad. Sci. 752, 19-29.
25. VANDENBURGH, H.H., DEL TATTO, M., SHANSKY, J., LEMAIRE, J., CHANG, A., PAYUMO, F., LEE, P., GOODYEAR, A., and RAVEN, L. (1996). Tissue engineered skeletal muscle organoids for reversible gene therapy. In Vitro Cell. Dev. Biol. 32, 53A.
26. VILE, R.G., and RUSSELL, S.J. (1995). Retroviruses as vectors. Br. Med. Bulletin 51, 12-30.
27. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
28. XIONG, W., CHAO, J., and CHAO, L. (1995). Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hypertension 25, 715-719.
29. YAO, S., and KURACHI, K. (1992). Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc. Natl. Acad. Sci. USA 89, 3357-3361.
30. YAO, S.-N., SMITH, K.J., and KURACHI, K. (1994). Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Gene Ther. 1, 99-107.